LON:SALV - SalvaRx Group Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
GBX 15 -2.50 (-14.29 %)
(As of 02/17/2019 04:00 PM ET)
Previous CloseGBX 15
Today's RangeGBX 11 - GBX 17.40
52-Week RangeGBX 17.54 - GBX 44.50
Volume56,814 shs
Average Volume49,570 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
SalvaRx Group plc discovers and develops immune-oncology drugs. The company is based in Ramsey, Isle of Man.

Receive SALV News and Ratings via Email

Sign-up to receive the latest news and ratings for SALV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone+44-1624-811611

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees2
OptionableNot Optionable

SalvaRx Group (LON:SALV) Frequently Asked Questions

What is SalvaRx Group's stock symbol?

SalvaRx Group trades on the London Stock Exchange (LON) under the ticker symbol "SALV."

What price target have analysts set for SALV?

0 brokerages have issued 12 month target prices for SalvaRx Group's stock. Their forecasts range from GBX 180 to GBX 180. On average, they expect SalvaRx Group's share price to reach GBX 180 in the next year. This suggests a possible upside of 1,100.0% from the stock's current price. View Analyst Price Targets for SalvaRx Group.

Has SalvaRx Group been receiving favorable news coverage?

News headlines about SALV stock have trended somewhat positive this week, InfoTrie reports. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. SalvaRx Group earned a coverage optimism score of 1.4 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 1.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future.

Who are some of SalvaRx Group's key competitors?

Who are SalvaRx Group's key executives?

SalvaRx Group's management team includes the folowing people:
  • Dr. Ian B. Walters, CEO & Exec. Director
  • Mr. Kamlesh Shah, Chief Financial Officer & Director (Age 67)

How do I buy shares of SalvaRx Group?

Shares of SALV and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is SalvaRx Group's stock price today?

One share of SALV stock can currently be purchased for approximately GBX 15.

What is SalvaRx Group's official website?

The official website for SalvaRx Group is https://www.salvarx.io/investors/aim-rule-26.html.

How can I contact SalvaRx Group?

SalvaRx Group's mailing address is Commerce House, 1 Bowring Road, RAMSEY, RAMSAY, IM8 2LQ, Isle of Man. The company can be reached via phone at +44-1624-811611.


MarketBeat Community Rating for SalvaRx Group (LON SALV)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  113 (Vote Outperform)
Underperform Votes:  89 (Vote Underperform)
Total Votes:  202
MarketBeat's community ratings are surveys of what our community members think about SalvaRx Group and other stocks. Vote "Outperform" if you believe SALV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SALV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel